Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-13FDA Approved: NABUMETONE — Original Application (Actavis Pharma, Inc.)
FDA approves the original application for Nabumetone as a generic (ANDA) drug manufactured by Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial evaluating fatigue in patients with anemia of chronic disease due to rheumatoid…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 study evaluated whether adding tocilizumab to methotrexate could prevent structural joint damage in adults with moderate-to-severe…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis [Phase 3]
A Phase 3 substudy evaluation of a low-dose abatacept in rheumatoid arthritis has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Phase IIIB Subcutaneous Missed Dose Study [Phase 3]
Phase IIIB subcutaneous missed-dose study in rheumatoid arthritis has completed, with results posted in 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy [Phase 3]
A Phase 3 clinical trial evaluated abatacept (BMS-188667) added to background non-biologic DMARDs in active rheumatoid arthritis patients wh…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Applications for Methotrexate Optimization in Rheumatoid Arthritis
A completed clinical trial update on optimizing methotrexate therapy for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome [Phase 3]
Phase 3 clinical trial update for moderate to severe dry eye syndrome, sponsored by Allergan, involving patients with Keratoconjunctivitis S…
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs [Phase 2]
A Phase 2 trial tested the Tick-Borne Encephalitis vaccine in rheumatoid arthritis patients taking immunosuppressants. The study has complet…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis [Phase 1]
Phase 1 safety study of CE 224,545 in combination with methotrexate in rheumatoid arthritis has completed, focusing on safety and tolerabili…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis [Phase 3]
Update on a Phase 3 trial evaluating infliximab in combination with methotrexate for early rheumatoid arthritis, focusing on safety and effi…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis. [Phase 3]
This completed Phase 3 trial evaluated the safety and effectiveness of Remicade (infliximab) in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis [Phase 1]
Phase 1 pharmacokinetic study of SCIO-469 in female patients with active rheumatoid arthritis to characterize absorption, distribution, meta…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol [Phase 4]
Phase 4 clinical trial update describing the iRAMT protocol for tapering methotrexate in rheumatoid arthritis patients treated with inflixim…
-
CLINICAL_TRIALS research · 2011-05-19Clinical Trial Update: Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept [Phase 3]
This Phase 3 open-label pilot trial investigates switching rheumatoid arthritis patients who have an incomplete response to etanercept to in…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects [Phase 4]
A Phase 4 trial evaluating the combination of etanercept and methotrexate in rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 3]
Phase IIIb trial evaluating BMS-188667 in patients with active rheumatoid arthritis who had an inadequate response to methotrexate. The stud…
-
CLINICAL_TRIALS research · 2011-05-17Clinical Trial Update: Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents
This clinical trial update reports on changes in the use of opioids, antidepressants, and benzodiazepines among rheumatoid arthritis patient…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis [Phase 3]
Phase 3 trial results evaluate the efficacy of the combination of Oncoxin and Viusid for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Effects of a Rehabilitation Program on Physical Performance and Disease Self-management in Rheumatoid Arthritis. [NA]
Completed clinical trial evaluating a rehabilitation program’s impact on physical performance and disease self-management in rheumatoid arth…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
Amgen-sponsored trial assessing DMARD intervention and utilization in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis [Phase 2]
Phase 2 study evaluating the safety and efficacy of intravenous ACZ885 in combination with oral methotrexate for patients with early rheumat…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial update for certolizumab pegol in active rheumatoid arthritis; results posted following completion.
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
Amgen-sponsored DMARD intervention and utilization trial for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis [Phase 3]
Phase III trial of BMS-188667 in active rheumatoid arthritis completed with results posted in May 2011.